(Reuters) – Merck Co Inc reported better-than-expected quarterly earnings despite the negative impact of the stronger dollar, with solid sales growth from its vaccines and treatments for diabetes and HIV. The No. 2 U.S. drugmaker said on Friday it earned $1.79 billion, or 58 cents per share, in the second quarter. That …
Merck quarterly earnings beat forecasts
July 27th, 2012 FAKE NEWS for the Zionist agenda